Coronary Artery Disease (CAD)
Coronary Artery Disease (CAD)

Reference for building the Care Pathway:

American Heart Association (AHA) - EUA

One of the most important and renowned institutions in the world for the study of cardiovascular diseases, including coronary artery disease (CAD).

Founded in 1924, the AHA is one of the leading international cardiovascular health organizations and plays a crucial role in research, education, and prevention of heart disease and strokes.

Caren has adopted the "Guidelines and Protocols for the Management of CAD" published by the AHA as a reference to structure its care line, ensuring comprehensive and effective patient monitoring.

Care Pathway for Coronary Artery Disease (CAD)

The Caren care line is reinforced by an intelligent system that continuously monitors patient data, allowing early detection of signs of decompensation or complications. The platform collects information from assessment questionnaires, laboratory tests, medical visit records, and cardiac parameter intervals, cross-referencing this data to generate personalized alerts for healthcare teams, promoting more precise and efficient management of CAD.
πŸ“‹ Steps:
1
Initial Assessment
2
Framingham Risk Score
3
Continuous Monitoring
Points
βœ… Main objectives:
  • βœ” Control cardiovascular risk factors by promoting treatment adherence and lifestyle changes.
  • βœ” Prevent new events with appropriate therapies.
  • βœ” Ensure that the patient follows medical guidance and achieves better outcomes in disease management.
πŸ“Œ Expected benefits:
  • βœ” Reduction of the risk of serious complications.
  • βœ” Improved control of risk factors.
  • βœ” Continuous follow-up and treatment adjustments as needed.
⚑Test now: